BEHANDLUNG UND PROPHYLAXE VON AMYLOIDOSE

European patent · EP2237803 · Deleted

Register entry

Publication number
EP2237803
Application number
EP08867535
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Dec 29, 2008
Published
Oct 13, 2010
Granted
Jul 1, 2015
Deleted
Jul 23, 2026
Reason
Annual fee unpaid
IPC classes
C12P 21/08 (2006.01)
A61P 43/00 (2006.01)
C07K 16/18 (2006.01)
Priority
US 7544 P 28.12.2007
US 95932 P 10.09.2008
PCT application
PCT/US2008/088493 29.12.2008
PCT publication
WO2009/086539 09.07.2009
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 23, 2026

    Deleted, fee unpaid

    Status of protective title
    Active → Cancelled
    Cancellation date
    23.07.2026
    Cause for cancellation
    Non-payment of renewal fee

    Published in Swissreg on 23.07.2026

  2. Jan 8, 2025

    Next annual fee due on

    Next annual fee due on
    31.12.2024 → 31.12.2025

    Published in Swissreg on 08.01.2025

  3. Jun 20, 2024

    Agent removed

    Owner
    Prothena Biosciences Limited, Adelphi Plaza, Upper George's Street, Dun Laoghaire, County Dublin, A96 T927, Ireland (removed)
    Representative
    VENI GmbH, Villa de Meuron, Buristrasse 21, 3006 Bern (removed)
    Inventor
    SCHENK, Dale, B., 1542 Altos Drive, Burlingame, CA 94010, USA, SEUBERT, Peter, A., 801 Castro Street, San Francisco, CA 94114, USA, WALL, Jonathan, 1216 Harrington Drive, Knoxville, TN 37922, USA, SALDANHA, Jose, 21 Fillebrook Avenue, Enfield, Middlesex EN1-3BD, United Kingdom (removed)
    Register addresses

    Published in Swissreg on 20.06.2024

  4. Jun 20, 2024

    Agent entered

    Register addresses
    Owner
    Prothena Biosciences Limited, Adelphi Plaza, Upper George's Street, Dun Laoghaire, County Dublin, A96 T927, Ireland
    Representative
    Isler & Pedrazzini AG, Postfach, 8027 Zürich
    Inventor
    SCHENK, Dale, B., 1542 Altos Drive, Burlingame, CA 94010, USA, SEUBERT, Peter, A., 801 Castro Street, San Francisco, CA 94114, USA, WALL, Jonathan, 1216 Harrington Drive, Knoxville, TN 37922, USA, SALDANHA, Jose, 21 Fillebrook Avenue, Enfield, Middlesex EN1-3BD, United Kingdom

    Published in Swissreg on 20.06.2024

  5. Jan 1, 2024

    Change

    Published in Swissreg on 01.01.2024

  6. Jan 10, 2023

    Change

    Published in Swissreg on 10.01.2023

  7. Sep 22, 2021

    Agent removed

    Representative
    VENI GmbH, Villa de Meuron, Buristrasse 21, 3006 Bern (removed)

    Published in Swissreg on 22.09.2021

  8. Jul 17, 2018

    Agent entered

    Representative
    VENI GmbH, Villa de Meuron, Buristrasse 21, 3006 Bern

    Published in Swissreg on 17.07.2018

4 earlier entries
  1. Jun 23, 2018

    Transferred

    Owner
    Prothena Biosciences Limited, 25-28 North Wall Quay, Dublin 1, Ireland → Prothena Therapeutics Limited, Adelphi Plaza, Upper George's Street, Dun Laoghaire, County Dublin, A96 T927, Ireland

    Published in Swissreg on 23.06.2018

  2. Jun 23, 2018

    Transferred

    Owner
    Prothena Therapeutics Limited, Adelphi Plaza, Upper George's Street, Dun Laoghaire, County Dublin, A96 T927, Ireland → Prothena Biosciences Limited, Adelphi Plaza, Upper George's Street, Dun Laoghaire, County Dublin, A96 T927, Ireland

    Published in Swissreg on 23.06.2018

  3. Oct 6, 2015

    Agent entered

    Representative
    VENI GmbH, Villa de Meuron, Buristrasse 21, 3006 Bern

    Published in Swissreg on 06.10.2015

  4. Jul 1, 2015

    Granted

    Published in Swissreg on 01.07.2015

Parties

Inventor

SCHENK, Dale, B.

Burlingame CA 94010, US

SEUBERT, Peter, A.

San Francisco CA 94114, US

WALL, Jonathan

Knoxville TN 37922, US

SALDANHA, Jose

Enfield Middlesex EN1-3BD, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.